Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO)

48 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q2 2024.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16.4M shares of 65.9M outstanding shares and own 24.91% of the company stock.
Largest 10 shareholders include AVENIR CORP (2.97M shares), Skylands Capital, LLC (2.84M shares), Granahan Investment Management, LLC (2.66M shares), VANGUARD GROUP INC (1.95M shares), NEUBERGER BERMAN GROUP LLC (1.54M shares), Sargent Investment Group, LLC (1.43M shares), CM Management, LLC (850K shares), BlackRock Inc. (656K shares), GEODE CAPITAL MANAGEMENT, LLC (435K shares), and STATE STREET CORP (140K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.